CN1326526C - 延长释放的药物组合物 - Google Patents

延长释放的药物组合物 Download PDF

Info

Publication number
CN1326526C
CN1326526C CNB2003801015269A CN200380101526A CN1326526C CN 1326526 C CN1326526 C CN 1326526C CN B2003801015269 A CNB2003801015269 A CN B2003801015269A CN 200380101526 A CN200380101526 A CN 200380101526A CN 1326526 C CN1326526 C CN 1326526C
Authority
CN
China
Prior art keywords
cefquinome
formulation
compositions
weight
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB2003801015269A
Other languages
English (en)
Chinese (zh)
Other versions
CN1705483A (zh
Inventor
P·施密德
A·伯特纳
C·施密特
M·阿伦
C·巴尔博
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Publication of CN1705483A publication Critical patent/CN1705483A/zh
Application granted granted Critical
Publication of CN1326526C publication Critical patent/CN1326526C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNB2003801015269A 2002-10-25 2003-10-20 延长释放的药物组合物 Expired - Lifetime CN1326526C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02079477.2 2002-10-25
EP02079477 2002-10-25

Publications (2)

Publication Number Publication Date
CN1705483A CN1705483A (zh) 2005-12-07
CN1326526C true CN1326526C (zh) 2007-07-18

Family

ID=32116298

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2003801015269A Expired - Lifetime CN1326526C (zh) 2002-10-25 2003-10-20 延长释放的药物组合物

Country Status (18)

Country Link
EP (1) EP1558263B1 (enExample)
JP (1) JP4584715B2 (enExample)
CN (1) CN1326526C (enExample)
AR (1) AR041713A1 (enExample)
AT (1) ATE327759T1 (enExample)
AU (1) AU2003279302B2 (enExample)
BR (2) BRPI0315513B1 (enExample)
CA (1) CA2501395C (enExample)
CO (1) CO5700769A2 (enExample)
DE (1) DE60305728T2 (enExample)
ES (1) ES2265590T3 (enExample)
MX (1) MXPA05004219A (enExample)
NO (1) NO334158B1 (enExample)
NZ (1) NZ539478A (enExample)
PL (1) PL208585B1 (enExample)
PT (1) PT1558263E (enExample)
WO (1) WO2004037265A1 (enExample)
ZA (1) ZA200502956B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007291308A1 (en) * 2006-08-30 2008-03-06 Intervet International B.V. Pharmaceutical compositions comprising cefquinome
AU2007234612B2 (en) 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
US7678764B2 (en) 2007-06-29 2010-03-16 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations for use at elevated temperatures
JP5323832B2 (ja) 2007-08-07 2013-10-23 アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー 酸性水溶液中にｇｄｆ−５を含むタンパク質製剤
BRPI0911048A2 (pt) 2008-04-14 2015-12-29 Atrm Llc formulações líquidas tamponadas de gdf-5
AR077320A1 (es) * 2009-07-20 2011-08-17 Intervet Int Bv Metodo para la preparacion de particulas de cefquinoma y formulaciones farmaceuticas que las comprenden.
AU2012206621B2 (en) * 2011-01-12 2017-04-27 Intervet International B.V. Use of liquid medium exchange by cross flow filtration in the preparation of drug suspensions
WO2012095438A1 (en) * 2011-01-12 2012-07-19 Intervet International B.V. Particles and suspensions of cephalosporin antibiotics
CN102319210B (zh) * 2011-09-29 2013-05-01 武汉回盛生物科技有限公司 一种兽用长效硫酸头孢喹肟注射液及其制备方法
CN104546703B (zh) * 2013-12-10 2017-06-23 中国农业科学院饲料研究所 一种奶牛泌乳期用硫酸头孢喹肟乳房注入剂及其制备方法
CN104000783B (zh) * 2014-05-14 2017-12-05 河南牧翔动物药业有限公司 头孢喹肟脂质体
CN104873462B (zh) * 2014-11-18 2017-04-05 中国农业科学院饲料研究所 一种奶牛干乳期用硫酸头孢喹肟乳房注入剂及其制备方法
CN107157927A (zh) * 2017-05-31 2017-09-15 合肥中龙神力动物药业有限公司 动物用硫酸头孢喹肟注射液及其制备方法
CN109044970A (zh) * 2018-11-08 2018-12-21 遂宁市中通实业集团动物药业有限公司 一种硫酸头孢喹肟注射液及其制备方法
CN113209014A (zh) * 2020-01-21 2021-08-06 江西邦诚动物药业有限公司 长效硫酸头孢喹肟混悬注射液及其制备工艺
CN113952298B (zh) * 2021-12-08 2023-02-17 江苏农牧科技职业学院 硫酸头孢喹肟纳米混悬液及其制备方法
CN117982413B (zh) * 2024-04-03 2024-06-18 山东恒邦中科生物工程有限公司 一种硫酸头孢喹肟注射液的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061149A1 (en) * 1999-04-07 2000-10-19 Takeda Schering-Plough Animal Health K.K. Long-acting antibacterial composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920819A (en) * 1974-12-02 1975-11-18 Lilly Co Eli Nonaqueous vehicle for oral pharmaceutical suspensions
IE49768B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
IE51846B1 (en) * 1980-11-17 1987-04-15 Leo Pharm Prod Ltd Pharmaceutical preparation for veterinary use and an appliance containing it
GB8531609D0 (en) * 1985-12-23 1986-02-05 Beecham Group Plc Compounds
JP3022692B2 (ja) * 1992-10-13 2000-03-21 三菱マテリアル株式会社 リーク検査装置
GB9306106D0 (en) * 1993-03-24 1993-05-12 Norbrook Lab Ltd Sustained release veterinary composition
DE4440141A1 (de) * 1994-11-10 1996-05-15 Hoechst Ag Neue kristalline Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung
WO2003063877A1 (en) * 2002-02-01 2003-08-07 Akzo Nobel N.V. Cefquinome composition for intra-mammary administration in cattle

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061149A1 (en) * 1999-04-07 2000-10-19 Takeda Schering-Plough Animal Health K.K. Long-acting antibacterial composition

Also Published As

Publication number Publication date
CA2501395A1 (en) 2004-05-06
DE60305728D1 (de) 2006-07-06
MXPA05004219A (es) 2005-06-08
NO334158B1 (no) 2013-12-23
BR0315513A (pt) 2005-08-23
ZA200502956B (en) 2006-03-29
JP4584715B2 (ja) 2010-11-24
ATE327759T1 (de) 2006-06-15
NO20051654L (no) 2005-05-24
AR041713A1 (es) 2005-05-26
ES2265590T3 (es) 2007-02-16
JP2006510607A (ja) 2006-03-30
AU2003279302B2 (en) 2008-10-16
EP1558263A1 (en) 2005-08-03
CN1705483A (zh) 2005-12-07
DE60305728T2 (de) 2006-10-12
NZ539478A (en) 2006-05-26
EP1558263B1 (en) 2006-05-31
PL208585B1 (pl) 2011-05-31
CO5700769A2 (es) 2006-11-30
BRPI0315513B1 (pt) 2017-11-28
CA2501395C (en) 2011-05-24
PT1558263E (pt) 2006-10-31
WO2004037265A1 (en) 2004-05-06
AU2003279302A1 (en) 2004-05-13
PL376840A1 (pl) 2006-01-09

Similar Documents

Publication Publication Date Title
CN1326526C (zh) 延长释放的药物组合物
EP0941095B1 (en) Improved pharmaceutical compositions
KR20050085037A (ko) 변형 비히클을 갖는 약학 조성물
CA2728727C (en) Pharmaceutical transdermal compositions and method for treating inflammation in cattle
US6911441B2 (en) Prolonged release pharmaceutical composition
HU205713B (en) Process for producing pharmaceutical compositions
US20020110561A1 (en) Pharmaceutical composition having modified carrier
Khalil et al. Ceftiofur pharmacokinetics in Nile tilapia Oreochromis niloticus after intracardiac and intramuscular administrations
CA2661099C (en) Pharmaceutical compositions comprising cefquinome
EP1197207A2 (en) Stable compositions for parenteral administration
US20020068065A1 (en) Pharmaceutical composition having specific water activity
Elkomy et al. Oral bioavailability of cefadroxil in healthy broiler chickens
WO2004032899A1 (en) Antibiotic formulation for intramammary administration in milking animals
Sayed et al. Pharmacokinetics and tissue residues of cephradine in healthy and experimentally Salmonella entretidis infected broiler chickens
JP2009513665A (ja) セフキノム組成物およびその使用方法
NZ574778A (en) Pharmaceutical compositions comprising cefquinome useful for the treatment of metritis in mammalian animals
TW200301126A (en) Methods of treating bacterial infections in dogs and cats
HK1156876B (en) Composition comprising an antibiotic and a corticosteroid
HK1156876A1 (en) Composition comprising an antibiotic and a corticosteroid

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: INTERVET INTERNATIONAL CO., LTD.

Free format text: FORMER OWNER: AKZO NOVEL N.V. CORP.

Effective date: 20061208

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20061208

Address after: Holland Haier box

Applicant after: INTERVET INTERNATIONAL B.V.

Address before: Holland Arnhem

Applicant before: AKZO NOBEL N.V.

C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term

Granted publication date: 20070718

CX01 Expiry of patent term